First Light, Mathew Arens report 10.8% stakes in Neogenomics (NEO)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Neogenomics, Inc. amendment filing reports that First Light Asset Management, LLC beneficially owns 13,631,016 shares (10.47%) and Mathew P. Arens beneficially owns 14,093,416 shares (10.82%). The filing is a joint Schedule 13G/A stating shared voting and dispositive power for the Manager and Mr. Arens.
Positive
- None.
Negative
- None.
Key Figures
First Light shares beneficially owned: 13,631,016 shares
First Light percent of class: 10.47%
Mathew P. Arens shares beneficially owned: 14,093,416 shares
+3 more
6 metrics
First Light shares beneficially owned
13,631,016 shares
Amount reported in Item 4 for First Light Asset Management, LLC
First Light percent of class
10.47%
Percent of class reported in Item 4 for First Light
Mathew P. Arens shares beneficially owned
14,093,416 shares
Amount reported in Item 4 for Mathew P. Arens
Mathew P. Arens percent of class
10.82%
Percent of class reported in Item 4 for Mathew P. Arens
Sole voting power (Arens)
200,000 shares
Sole power to vote reported for Mathew P. Arens in Item 4
Filing signature date
05/07/2026
Execution dates for signatures on the amendment
Key Terms
Schedule 13G/A, beneficial owner, shared dispositive power, joint filing agreement
4 terms
Schedule 13G/A regulatory
"Jointly filed Amendment No. 1 reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficial owner regulatory
"The Manager may be deemed to be the beneficial owner of 13,631,016 of the Issuer's shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
joint filing agreement regulatory
"Exhibit A: Joint Filing Agreement"
FAQ
What does Neogenomics (NEO) Schedule 13G/A amendment show?
It reports ownership stakes: First Light holds 13,631,016 shares (10.47%) and Mathew P. Arens holds 14,093,416 shares (10.82%). The filing lists shared voting and dispositive power and is a joint declaration under Section 13(d).
Who is filing the Schedule 13G/A for NEO?
The filing is jointly made by First Light Asset Management, LLC and Mathew P. Arens. The Manager advises separate accounts and private funds; Mr. Arens is managing member and majority owner and also holds shares directly and in a joint account.
How much voting control is reported in the NEO filing?
The filing shows shared voting power of 13,631,016 shares for First Light and 13,893,416 shares for Mr. Arens, with sole voting power of 200,000 shares held directly by Mr. Arens as disclosed in Item 4.
When was the Schedule 13G/A signed for Neogenomics (NEO)?
The signatures on the amendment show execution dates of 05/07/2026 by Kurt T. Peterson (Chief Compliance Officer) and 05/07/2026 by Mathew P. Arens (Chief Executive Officer) as indicated in the filing.